In HNSCC, we found that CASP1 is upregulated in tumor tissues (Table S2, p < .01), and it seemed to be a bad prognostic biomarker (HR > 1), indicating CASP1 might be a tumor‐promoting gene in HNSCC. The gene discussed is CASP1; the disease is neoplasm.